Articles by Disease (Hematological Malignancies)

Clinical Characteristics and Risk Factors for Bloodstream Infections in Children with Cancer: A Report from a Pediatric Hematology Oncology Unit

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 21
Page: 193-201
Author(s): Athanasios Bangeas, Efthymia Protonotariou, Emmanuel Hatzipantelis, Maria Palabougiouki, Maria Ioannidou, Lemonia Skoura, Assimina Galli-Tsinopoulou and Athanasios Tragiannidis*

Protein Lysine Methyltransferases Inhibitors

Journal: Current Medicinal Chemistry
Volume: 30
Page: 3060-3089
Author(s): Ying Li, Lei Ding, Shuang Ren, Wen Zhang and Guo-Wu Rao*

Multi-targeted HDAC Inhibitors as Anticancer Agents: Current Status and Future Prospective

Journal: Current Medicinal Chemistry
Volume: 30
Page: 2762-2795
Author(s): Vijay K. Patel, Ekta Shirbhate, Priya Tiwari, Rakesh Kore, Ravichandran Veerasamy, Achal Mishra and Harish Rajak*

Current Advances and Prospects in Carbon Nanomaterials-based Drug Deliver Systems for Cancer Therapy

Journal: Current Medicinal Chemistry
Volume: 30
Page: 2710-2733
Author(s): Chunmei Lai, Linyan Li, Bangyue Luo, Jiangwen Shen and Jingwei Shao*

Hybrid Histone Deacetylase Inhibitor: An Effective Strategy for Cancer Therapy

Journal: Current Medicinal Chemistry
Volume: 30
Page: 2267-2311
Author(s): Jiyong Wu*, Jing Nie, Yepeng Luan and Yanjiao Ding*

Carvacrol as a Prospective Regulator of Cancer Targets/Signalling Pathways

Journal: Current Molecular Pharmacology
Volume: 16
Page: 542-558
Author(s): Jyoti Singh, Suaib Luqman* and Abha Meena*

Anti-Cancer Role of Dendrosomal Nano Solanine in Chronic Myelogenous Leukemia Cell Line through Attenuation of PI3K/AKT/mTOR Signaling Pathway and Inhibition of hTERT Expression

Journal: Current Molecular Pharmacology
Volume: 16
Page: 592-608
Author(s): Golareh Asgaritarghi, Seyedeh Sahar Mortazavi Farsani, Dina Sadeghizadeh, Farhood Najaﬁ and Majid Sadeghizadeh*

Dysregulated YAP1/Hippo Pathway Contributes to Doxorubicin (ADM) Resistance in Acute Myeloid Leukemia (AML)

Journal: Current Pharmaceutical Biotechnology
Volume: 24
Page: 676-685
Author(s): Yan Song, Xi Chen*, Rui Huang and Juan Liu

Targeting Glutaminolysis to Treat Multiple Myeloma: An In Vitro Evaluation of Glutaminase Inhibitors Telaglenastat and Epigallocatechin-3-gallate

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23
Page: 779-785
Author(s): Chen Li, Yuhu Feng*, Weiguo Wang, Lingyun Xu, Miao Zhang, Yue Yao, Xiaoqian Wu, Qin Zhang, Wenyue Huang, Xiuxiu Wang, Xue Li, Peipei Ying and Liu Shang

Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases

Journal: Current Medicinal Chemistry
Volume: 30
Page: 2075-2112
Author(s): Il-Sup Kim, Woong-Suk Yang* and Cheorl-Ho Kim*